Clinical Scorecard: The Impact of Daily Light Exposure and Activity Patterns on the Risk of MASLD: Findings from Two National Cohort Analyses

At a Glance

Key Highlights

• Higher relative amplitude (RA) and greater daytime activity (M10) are associated with reduced MASLD risk.
• Increased activity during least active periods (L5) and delayed L5 onset correlate with higher MASLD risk.
• Greater daytime light exposure (>6000 lux) lowers MASLD risk, while increased nocturnal light exposure (>30 lux) raises risk.

Guideline-Based Recommendations

Diagnosis

• Use Fatty Liver Index (FLI) or US Fatty Liver Index (USFLI) for MASLD risk assessment in epidemiologic studies.

Management

• Promote increased daytime light exposure and regular rest-activity rhythms to reduce MASLD risk.
• Minimize nocturnal light exposure to prevent circadian disruption and MASLD progression.

Monitoring & Follow-up

• Monitor 24-hour rest-activity rhythms using accelerometry to assess risk and guide lifestyle interventions.

Risks

• Excessive nocturnal light exposure and disrupted rest-activity rhythms increase risk of MASLD, fibrosis, and cirrhosis.

Patient & Prescribing Data

Adults without baseline MASLD or other liver diseases, excluding those with excessive alcohol use or viral hepatitis

Behavioral modification focusing on optimizing light exposure and circadian rhythm regulation may reduce MASLD incidence and progression.

Clinical Best Practices

• Assess and counsel patients on maintaining regular rest-activity cycles with high daytime activity and low nighttime activity.
• Encourage exposure to natural daylight exceeding 6000 lux for at least one hour daily.
• Advise minimizing exposure to artificial light at night above 30 lux to protect circadian health.
• Use accelerometry data when available to objectively evaluate patient circadian patterns and tailor interventions.

References

• NHANES Study Data
• UK Biobank Ethics Approval